1-20 of 34
Authors: Katherine B Peters
Save search
Sort by
Journal Article
EDITOR'S CHOICE

The role of vorasidenib in the treatment of isocitrate dehydrogenase-mutant glioma Get access

PDF
Macarena I de la Fuente and others
Neuro-Oncology, noae259, https://doi.org/10.1093/neuonc/noae259
Published: 25 December 2024
Journal Article

NIMG-77. MRI PHENOMENON OF PUNCTATE ENHANCING LESIONS IN PATIENTS TREATED WITH IDH INHIBITORS Free

PDF
Michal Nisnboym Ziv and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii213, https://doi.org/10.1093/neuonc/noae165.0841
Published: 11 November 2024
Journal Article

INNV-07. IVOSIDENIB AND BEVACIZUMAB IN HEAVILY PRETREATED PATIENTS WITH IDH1 MUTANT GLIOMAS Free

PDF
Mallika P Patel and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii170, https://doi.org/10.1093/neuonc/noae165.0670
Published: 11 November 2024
Journal Article

INNV-37. REAL-WORLD OUTCOMES AMONG HIGH GRADE IDH1-MUTANT GLIOMA PATIENTS TREATED WITH AN IDH INHIBITOR Free

PDF
Michal Nisnboym Ziv and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Pages viii176–viii177, https://doi.org/10.1093/neuonc/noae165.0698
Published: 11 November 2024
Journal Article

CTNI-53. A GLOBAL, RANDOMIZED, DOUBLE-BLINDED, PHASE 3 STUDY OF VORASIDENIB VERSUS PLACEBO IN PATIENTS WITH ADULT-TYPE DIFFUSE GLIOMA WITH AN IDH1/2 MUTATION (INDIGO): UPDATED EFFICACY RESULTS Free

PDF
Ingo K Mellinghoff and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Pages viii108–viii109, https://doi.org/10.1093/neuonc/noae165.0420
Published: 11 November 2024
Journal Article

CTIM-13. D2C7-IT IN COMBINATION WITH AN FC-ENGINEERED ANTI-HUMANCD40 MONOCLONAL ANTIBODY (2141-V11) ADMINISTERED INTRATUMORALLY VIA CONVECTION-ENHANCED DELIVERY (CED) FOLLOWED BY CERVICAL PERILYMPHATIC INJECTIONS (CPLIS) OF 2141-V11 IN PATIENTS WITH RECURRENT GLIOBLASTOMA (RGBM) Free

PDF
Annick Desjardins and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii87, https://doi.org/10.1093/neuonc/noae165.0346
Published: 11 November 2024
Journal Article

CTNI-30. A PHASE 2 DOUBLE-BLIND, RANDOMIZED, PROSPECTIVE, PLACEBO CONTROLLED STUDY OF NANO₂TM COMBINED WITH RADIATION AND TEMOZOLOMIDE IN PATIENTS WITH NEWLY-DIAGNOSED GLIOBLASTOMA: RESTORE Free

PDF
Michael A Badruddoja and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii102, https://doi.org/10.1093/neuonc/noae165.0397
Published: 11 November 2024
Journal Article
EDITOR'S CHOICE

The biological significance of tumor grade, age, enhancement, and extent of resection in IDH-mutant gliomas: How should they inform treatment decisions in the era of IDH inhibitors? Open Access

PDF
Martin J van den Bent and others
Neuro-Oncology, Volume 26, Issue 10, October 2024, Pages 1805–1822, https://doi.org/10.1093/neuonc/noae107
Published: 24 June 2024
Journal Article

INDIGO: A GLOBAL, RANDOMIZED, DOUBLE-BLINDED, PHASE 3 STUDY OF VORASIDENIB VERSUS PLACEBO IN PATIENTS WITH RESIDUAL OR RECURRENT GRADE 2 GLIOMA WITH AN IDH1/2 MUTATION Free

PDF
Catherine McBain and others
Neuro-Oncology, Volume 25, Issue Supplement_3, October 2023, Page iii6, https://doi.org/10.1093/neuonc/noad147.025
Published: 16 September 2023
Journal Article

PATH-22. CLINICAL FEATURES AND MOLECULAR CHARACTERIZATION OF LEPTOMENINGEAL DISEASE IN PATIENTS WITH HIGH GRADE GLIOMA Free

PDF
Madison Shoaf and others
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Pages vii154–vii155, https://doi.org/10.1093/neuonc/noac209.595
Published: 14 November 2022
Journal Article

QOL-08. PHASE II RANDOMIZED STUDY TO EVALUATE EFFICACY AND SATISFACTION OF ROLAPITANT PLUS ONDANSETRON VS. ONDANSETRON MONOTHERAPY IN PREVENTING NAUSEA/VOMITING FOR GLIOMAS RECEIVING RADIATION/TEMOZOLOMIDE Free

PDF
Mary Lou Affronti and others
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii242, https://doi.org/10.1093/neuonc/noac209.935
Published: 14 November 2022
Journal Article

CTNI-49. EARLY SIGNAL OF ACTIVITY FROM A PHASE 2 STUDY OF ST101, A FIRST-IN-CLASS PEPTIDE ANTAGONIST OF CCAAT/ENHANCER-BINDING PROTEIN Β (C/EBPΒ), IN RECURRENT GLIOBLASTOMA (GBM) Free

PDF
Fabio Iwamoto and others
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii83, https://doi.org/10.1093/neuonc/noac209.314
Published: 14 November 2022
Journal Article

CTIM-07. PHASE II RANDOMIZED, BLINDED, PLACEBO-CONTROLLED TRIAL TESTING PP65 CMV MRNA DENDRITIC CELL VACCINE AND TETANUS-DIPHTHERIA TOXOID FOR NEWLY DIAGNOSED GBM (ATTAC II, NCT02465268) Free

PDF
Maryam Rahman and others
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Pages vii60–vii61, https://doi.org/10.1093/neuonc/noac209.239
Published: 14 November 2022
Journal Article

CTIM-23. DOSE ESCALATION TRIAL OF FC-ENGINEERED ANTI-CD40 MONOCLONAL ANTIBODY (2141-V11) ADMINISTERED INTRATUMORALLY WITH D2C7-IT VIA CONVECTION-ENHANCED DELIVERY (CED) FOR RECURRENT MALIGNANT GLIOMAS (RMGS) Free

PDF
Annick Desjardins and others
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii65, https://doi.org/10.1093/neuonc/noac209.255
Published: 14 November 2022
Journal Article

QOL-06. PREDICTING VENOUS THROMBOEMBOLISM IN PATIENTS WITH ADULT-TYPE DIFFUSE GLIOMAS Free

PDF
Kirsten B Burdett and others
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Pages vii241–vii242, https://doi.org/10.1093/neuonc/noac209.934
Published: 14 November 2022
Journal Article

QLTI-25. CREATING A CHEMOTHERAPY COMPETENCY METRIC FOR NEURO-ONCOLOGY FELLOWSHIP TRAINEES Free

PDF
Katherine B Peters and others
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii240, https://doi.org/10.1093/neuonc/noac209.927
Published: 14 November 2022
Journal Article

QOLP-28. COMPARING KNOWLEDGE OF AND BELIEFS ABOUT PALLIATIVE CARE AMONG NEURO-ONCOLOGY PATIENTS, CAREGIVERS, PROVIDERS AND A NATIONALLY-REPRESENTATIVE U.S. SAMPLE Free

PDF
Margaret Johnson and others
Neuro-Oncology, Volume 23, Issue Supplement_6, November 2021, Page vi189, https://doi.org/10.1093/neuonc/noab196.748
Published: 12 November 2021
Journal Article

A broad perspective on evaluating bias in the neuro-oncology workplace Free

PDF
Priya Kumthekar and others
Neuro-Oncology, Volume 23, Issue 3, March 2021, Pages 498–499, https://doi.org/10.1093/neuonc/noaa286
Published: 06 February 2021
Journal Article

Volumetric analysis of IDH-mutant lower-grade glioma: a natural history study of tumor growth rates before and after treatment Free

PDF
Raymond Y Huang and others
Neuro-Oncology, Volume 22, Issue 12, December 2020, Pages 1822–1830, https://doi.org/10.1093/neuonc/noaa105
Published: 24 April 2020
Journal Article

Safety and efficacy of VB-111, an anticancer gene therapy, in patients with recurrent glioblastoma: results of a phase I/II study Open Access

PDF
Andrew J Brenner and others
Neuro-Oncology, Volume 22, Issue 5, May 2020, Pages 694–704, https://doi.org/10.1093/neuonc/noz231
Published: 17 December 2019